CurveBeam AI Limited (ASX:CVB – Get Free Report) insider Arun Singh purchased 332,280 shares of the stock in a transaction dated Wednesday, October 16th. The stock was purchased at an average cost of A$0.15 ($0.10) per share, for a total transaction of A$48,180.60 ($32,120.40).
CurveBeam AI Stock Performance
About CurveBeam AI
CurveBeam AI Limited engages in the development and manufacture of point-of care specialized weight bearing medical imaging equipment in Europe and North America. The company builds artificial intelligence tools to aid in bone separation and segmentation, empowering orthopedic surgeons to make 3D-based deformity measurements to inform clinical decisions.
Further Reading
- Five stocks we like better than CurveBeam AI
- What is the Shanghai Stock Exchange Composite Index?
- Why Meta’s Pre-Earnings Dip Could Be A Golden Entry Opportunity
- Insider Trades May Not Tell You What You Think
- Spirit Airlines Stock Nearly Doubled: Are Clear Skies Ahead?
- Health Care Stocks Explained: Why You Might Want to Invest
- Tesla Stock: Buy the Dips, Sell the Rips
Receive News & Ratings for CurveBeam AI Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CurveBeam AI and related companies with MarketBeat.com's FREE daily email newsletter.
